The venom of amphibians is a fascinating source of active substances. In view of their medical importance and aiming to explore the amazing Brazilian biodiversity, we conducted bioprospecting of antiproliferative activity in extracts of Rhinella marina and Rhaebo guttatus toads occurring in the Southern Amazon of Mato Grosso, Brazil. LC-MS and HPLC analysis of the venom extracts of R. marina revealed four bufadienolides (telocinobufagin -1, marinobufagin -2, bufalin -3 and resibufogenin -4). R. guttatus venom extracts contained only marinobufagin (2). First, R. marina and R. guttatus venom extracts were evaluated for cytotoxicity against tumor cell lines by the MTT assay. All extracts revealed cytotoxicity, where R. marina extracts were comparable to doxorubicin (IC 50 values ranging from 0.01 to 0.23 mg/ mL). Only extracts of R. guttatus toad venom caused membrane disruption of human erythrocytes. The extracts were investigated for selective activity by determining their effect on stimulated human peripheral blood mononuclear cells (PBMC) with the Alamar BlueÔ assay. The extracts were up to 80-fold more selective against leukemia cells when compared to dividing leukocytes. Aiming to confirm these antiproliferative effects, BrdU incorporation into DNA was measured in HL-60 treated cells with R. marina venom extracts. These extracts decreased BrdU incorporation at both concentrations tested. In summary, nine extracts of R. marina and R. guttatus venom showed pronounced lethal and discriminating effects on tumor lines, especially those from R. marina, highlighting toad parotoid gland secretions as a promising source for novel lead anticancer chemicals.
Introduction
Bioprospecting of secondary metabolites can be an important contribution to economic growth in developing countries. Thousands of new compounds can arise from prospecting programs and indicate new bioactive and/or prototypes for pharmaceutical development. In this context, animals, plants, fungi and bacteria are important sources of biologically active substances with structural diversity and novel mechanisms of action, which can possibly provide patentable products (Rocha et al., 2001; Clardy and Walsh, 2004; Cunha-Filho et al., 2010; Ferreira et al., 2011a Ferreira et al., , 2011b Vieira Júnior et al., 2011; Militão et al., 2012) .
The family Bufonidae possesses 33 genera and 471 species (Pramuk, 2006) . It has a cosmopolitan distribution, except in Madagascar and Antarctica areas. Rhinella (formerly Bufo in the New World), the main genus of the family, consists of about 258 species. In Latin America, they are found in the Amazon regions of Brazil, Bolivia, Colombia, Peru, Suriname, Guiana and Venezuela (Frost et al., 2006) .
The skin secretions and venom of amphibians are fascinating sources of active compounds, such as peptides, alkaloids, bufadienolides, biogenic amines and proteins. These molecules play a crucial role in the physiological functions of these animals, especially for predation and protection against microorganisms. In toads, particularly, the key compounds are biogenic amines and digitalis-like aglycones called bufadienolides, an important group of polyhydroxy C-24 steroids related to cholesterol, which have a 2-pyrone group attached at the C-17 position of the perhydrophenanthrene nucleus (Toledo and Jared, 1995; Dmitrieva et al., 2000; Xu-Tao et al., 2009; Yang et al., 2010; Gao et al., 2011) . Structure-activity relationship studies of these compounds have shown cardiotonic (Imai et al., 1965) , antiviral (Kamano et al., 1988; Wang et al., 2011) , cytotoxic (Cunha-Filho et al., 2010; Gao et al., 2011; Sciani et al., 2012) , antibacterial (Cunha-Flho et al., 2005) , antiparasitic (Tempone et al., 2008) and insecticidal (Supratman et al., 2000) properties.
Animals contain a large assortment of structurally unique secondary metabolites that can be useful as new chemical templates for drug discovery (Rocha et al., 2001; Cunha-Filho et al., 2010) . Although amphibian skin secretions have proved to be a rich source of exclusive molecules, they remain largely underexplored or entirely unexplored and represent a great potential for the development of new molecular models for pharmacological and toxicological evaluations and even for synthesis and medicinal chemistry. Our objectives has been to explore the biodiversity of Brazil, a country with the largest number of species in the world, possessing more than a hundred thousand species of invertebrates and about 8200 vertebrates. Therefore, we conducted bioprospecting in extracts of Rhinella marina (synonymy Bufo marinus) and Rhaebo guttatus toads occurring in the Southern Amazon of Mato Grosso, Brazil, in search of venoms with cytotoxic activity against tumor and normal cells. Antiproliferative activity in extracts was assessed using the BrdU immunocytochemistry assay.
Material and methods

Qualitative HPLC and LC-ESIMS analysis
Analytical HPLC was performed on a Varian HPLC system Pro Star 325 LC plus UV detector, Pro Star 325 dual wavelength system. Electrospray ionization (ESI) mass spectra were acquired in the positive ion mode on a LC-MS system LCQ FLEET instrument (Thermo scientific) equipped with an ion-trap mass analyzer. Chromatographic separation was carried out in a Phenomenex Luna C18 column (250.0 mm Â 4.6 mm, 5 mm). The mobile phase consisted of MeCN and water. A multistep gradient program was used as follows: 8% MeCN (0 min), 54% MeCN (45 min), 54% MeCN (55 min) and 95% MeCN (70 min). The flow rate was 0.8 mL/ min, injection volume was 20 mL (4 mg/mL), and UV detection was at 296 nm (Gao et al., 2010) .
Sample collection
Toad venom was collected from the secretion of R. marina and R. guttatus in Mato Grosso State, Brazil. The animals were identified by one of the authors (D. J. Rodrigues -IBAMA, SISBIO: number 30034-1). Voucher specimens (R. marina -ABAM-H 1262 and R. guttatus -ABAM-H 1538) were deposited in the Acervo Biológico da Amazônia Meridional (Sinop, Mato Grosso, Brazil).
Extraction of toad venom samples and standards
Nine samples (10.0 mg each) of toad venom of R. marina and R. guttatus were separated by gender (male/female), dried, powdered and extracted three times (5 mL) with CHCl 3 /MeOH (8:2) by ultrasonication for 10 min at room temperature. The extracts were qualitatively analyzed by HPLC and LC-MS, and they were identified by the following codes: RMF -R. marina female, RMM -R. marina male, RGF -R. guttatus female and RGM -R. guttatus male (Gao et al., 2010) . Reference standards of two authentic bufadienolides, namely telocinobufagin and marinobufagin, were supplied by Dr. Geraldino A. Cunha-Filho (University of Brasilia, Brazil).
Culture of normal and tumor cells
Heparinized human blood samples (from healthy, nonsmoker donors who had not taken any drug for at least 15 days prior to sampling, aged 18-35 years old) were collected, and peripheral blood mononuclear cells (PBMC) were isolated by the standard method of density-gradient centrifugation over Ficoll-Hypaque. All studies were performed in accordance with Brazilian research guidelines (Law 196/96, National Council of Health) and with the Declaration of Helsinki.
Leukemia (HL-60), colon (HCT-116), glioblastoma (SF-295) and ovarian (OVCAR-8) tumor cells and PBMC were grown in RPMI-1640 medium supplemented with 20% fetal bovine serum, 2 mM glutamine, 100 U/mL penicillin and 100 mg/mL streptomycin, at 37 C in a 5% CO 2 atmosphere.
Cytotoxicity assays
The cytotoxic properties of the extracts were assessed by colorimetric assays after 72 h exposure using HL-60, SF-295, HCT-116, OVCAR-8 and PMBC. Cell proliferation was determined spectrophotometrically using a multiplate reader (DTX 880 Multimode Detector, Beckman Coulter). Control groups (negative and positive) received the same amount of dimethylsulfoxide solvent (0.1% DMSO) as test groups. Doxorubicin (Dox, 0.005-5.0 mg/mL) was used as positive control.
MTT assay
The cytotoxicity against HL-60, SF-295, HCT-116 and OVCAR-8 human cancer cells was determined by the MTT assay (Mosmann, 1983) , which analyzes the ability of living cells to reduce the yellow dye 3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl-2H-tetrazolium bromide (MTT) to a purple formazan product. Briefly, cells were plated in 96-well plates (0.3-0.7 Â 10 5 cells/well) and incubated to allow cell adhesion or equilibration (suspension cultures). Twenty-four hours later, extracts were added to each well (0.004-50 mg/mL). After 69 h of incubation, the supernatant was replaced with fresh medium containing 10% MTT, and the cells incubated for an additional 3 h. The plates were then centrifuged and the formazan product was dissolved in DMSO; absorbance was read at 595 nm.
Alamar Blue assay
The selectivity of the extracts was investigated in human PBMC using the Alamar BlueÔ assay. PBMC were washed and resuspended (3 Â 10 5 cells/mL) in supplemented RPMI-1640 medium plus 4% phytohemagglutinin for growth stimulation. PBMC were then plated in 96-well plates (3 Â 10 5 cells/well in 100 mL of medium). After 24 h, extracts dissolved in DMSO were added to each well (0.004-50 mg/ mL) and the cells were incubated for 72 h. Twenty-four hours before the end of the incubation, 10 mL of Alamar BlueÔ stock solution (0.312 mg/mL) (Resazurin; Sigma Aldrich Co., USA) were added to each well. The absorbance was read at 570 and 595 nm and the drug effect was expressed as the percentage of the control (Ferreira et al., 2011b ).
Membrane analysis assay
The extracts were assayed for hemolytic activity according to the method of Santos et al. (2010) , with some modifications. Extracts (1.56-200 mg/mL) were incubated in 96-well plates for 60 min at room temperature (25 C) in a suspension of human erythrocytes (2%) in 0.85% NaCl containing 10 mM CaCl 2 . After centrifugation, hemoglobin levels in the supernatants were spectrophotometrically determined at 540 nm.
Inhibition of DNA synthesis
The BrdU assay is a reliable in vitro non-radioactive method, which is very often used to directly quantify cell proliferation (Costa et al., 2008; Ferreira et al., 2010) . Accordingly, HL-60 cells were plated in 24-well tissue culture plates (1 mL/well) and treated with R. marina extracts (RMF-1, RMF-2, RMF-3, RMF-4 and RMM-5) at concentrations of 0.1 and 1 mg/mL for 24 h. Before the end of drug exposure, 10 mL of 10 mM 5-bromo-2 0 -deoxyuridine (BrdU) were added to each well and the cells incubated for an additional 3 h at 37 C. To determine the amount of BrdU incorporated into DNA, cells were first harvested, transferred to cytospin slides, and allowed to dry for 2 h at room temperature (Pera et al., 1977) . Cells that incorporated BrdU were labeled by direct peroxidase immunocytochemistry, using the chromogen diaminobenzidine (DAB). Slides were counterstained with hematoxylin. Cells were scored for BrdU positivity by light microscopy (Olympus, Tokyo, Japan), where 200 cells were counted per slide to determine the percentage of BrdUpositive cells.
Statistical analysis
The IC 50 and EC 50 values and their 95% confidence intervals were obtained by nonlinear regression using the GraphPad program (Intuitive Software for Science, San Diego, CA). Differences were evaluated by comparing data using one-way analysis of variance (ANOVA) followed by the Newman-Keuls test (p < 0.05). All studies were carried out in triplicate and represented independent biological evaluations.
Results
As shown in Fig. 1 , the chromatographic profile revealed four bufadienolides in R. marina extracts (RMF-1 and RMM-5), namely telocinobufagin (1), marinobufagin (2), bufalin (3) and resibufogenin (4) (Figs. 1 and 2), whereas in R. guttatus venom (RGF-6 and RGM-9), only one bufadienolide was identified (marinobufagin -2). The compounds were identified by comparison of retention times with standards and on the basis of UV and mass spectra. These findings are in agreement with previous data for B. marinus (Gao et al., 2010) .
Regarding the biological assessments, the cytotoxicity of R. marina and R. guttatus venom extracts was first evaluated in a variety of tumor cell lines after 72 h exposure using the colorimetric MTT assay. All extracts of R. marina male/female venoms revealed higher cytotoxic activity, with IC 50 values ranging from 0.01 mg/mL (HL-60); RMF-3 and RMF-4 (SF-295) and RMF-3 (HCT-116)] to 0.23 mg/mL (OVCAR-8) (Table 1) . Meanwhile, R. guttatus venom extracts exhibited a lower cytotoxic effect when compared to those of R. marina, with their IC 50 values being around 2.9-6.6 mg/mL. Second, the cytotoxicity of the extracts was determined against normal cells, using human PBMC for this purpose. Herein, higher IC 50 values were found for proliferating leukocytes (0.8, 0.5, 0.4, 0.3, 1.1, 0.8, 16, 13.1 and 13.9 mg/mL for RMF-1, RMF-2, RMF-3, RMF-4, RMM-5, RGF-6, RGF-7, RGF-8 and RGM-9, respectively) ( Table 2) . Statistically, there were no differences in the cytotoxicity outcomes between samples obtained from female and male animals belonging to the same species (p > 0.05).
To better understand this potent cytotoxic activity, in vitro cytolytic analyses were performed with human erythrocytes. Interestingly, the most promising extracts obtained from R. marina (RMF-1, RMF-2, RMF-3, RMF-4 and RMM-5) were not able to cause hemolysis even at the highest concentration tested (200 mg/mL) ( Table 2 ). On the other hand, all R. guttatus venom extracts led to hemolysis, with EC 50 values ranging from 20.8 (RGF-8) to 33.7 mg/mL (RGF-6).
BrdU incorporation into DNA was measured in HL-60-treated cells with R. marina venom extracts after 24 h exposure. As seen in Fig. 3 , all extracts (RMF-1, RMF-2, RMF-3, RMF-4 and RMM-5) decreased BrdU incorporation, showing labeling of 35.4 AE 3.4, 30.7 AE 1.0, 25.1 AE 1.8, 28.0 AE 1.7 and 38.3 AE 2.6% at 0.1 mg/mL and 19.7 AE 1.3, 19.6 AE 1.2, 15.8 AE 1.8, 16.5 AE 0.8 and 29.5 AE 1.6% at 1 mg/mL, respectively, when compared to untreated cells (73.0 AE 3.2%) (p < 0.05). Dox (0.1 and 1 mg/mL) treatment resulted in 22.6 AE 1.9 and 12.7 AE 0.9% BrdU incorporation (p < 0.05). 
Discussion
Drug discovery and development have established a respectable armamentarium of useful chemotherapeutic agents as well as a number of important successes in the treatment and management of human cancer. Nevertheless, the most common tumors are resistant to current antineoplastic drugs and the majority of these agents have only limited activity against solid tumors (Harris, 2002; Srivastava et al., 2005) . However, research on antiproliferative compounds has still demonstrated the great pharmacological importance of biological extracts (Clardy and Walsh, 2004; Cragg and Newman, 2005; Ferreira et al., 2011b) .
In the last decades, toads have received special attention, with many publications describing the biological activities of molecules and aqueous and organic extracts obtained from skin glands, whose secretions exhibit bufadienolides, compounds that may act as endogenous steroidal hormones (Schoner and Scheiner-Bobis, 2005 ) and display antiangiogenic (Lee et al., 1997) , antihypertensive (Vu et al., 2006) , immunosuppressive (Terness et al., 2001 ), anti-endometrial (Nasu et al., 2005) and positive inotropic (Cruz and Matsuda, 1993) actions. Herein, we investigated the chemical composition of extracts of R. marina and R. guttatus venoms and their antiproliferative activity in transformed and normal cells.
Chemical investigations showed significant differences in composition between R. marina and R. guttatus venoms, in terms of the number and type of constituents. R. marina venom contained four bufadienolides, namely telocinobufagin (1), marinobufagin (2), bufalin (3) and resibufogenin (4) (Figs. 1 and 2 ), whereas only one bufadienolide (marinobufagin -2) was identified in R. guttatus venom. No obvious chemical differences were observed between male and female toads. These compounds have also been identified in other toad species such as Rhinella schneideri, Bufo bufo gargarizans, Bufo melanosticus, Bufo viridis and Bufo rubescens (Gao et al., 2010; Cunha-Filho et al., 2010 . There are a number of potential reasons for this variation in venom composition such as species-specific differences, the diet of each species, and environmental factors (Gao et al., 2010) . The chemical profile of the toad venoms (R. marina and R. guttatus) in terms of the number and type of compounds present is mainly determined by the species of origin.
Venom extracts from R. marina and R. guttatus (male and female) showed cytotoxic activity against cancer lines after 72 h exposure, mainly R. marina extracts, whose IC 50 values were comparable to that of the positive control Dox. According to the American National Cancer Institute (NCI), an IC 50 30 mg/mL is needed to consider a crude extract promising for further purification and biological analyses (Suffness and Pezzuto, 1990; Ferreira et al., 2011b) . Previous in vitro analyses have already demonstrated a multiplicity of bufadienolides with cytotoxic potential. These compounds include gamabufotalin rhamnoside, bufotalin, hellebrin, epoxy-marinobufagin, bufalin, bufalin 3-acetate, hellebregenin, hellebregenin 3-acetate, resibufogenin 3-acetate, marinobufagin, marinobufagin 3-acetate, cinofagin, telocinobufagin, 3b-acetoxy-marinobufagin, 3b-acetoxy-bufalin, 3b-acetoxy-telocinobufagin and 20S,21R-epoxy-marinobufagin, isolated from skin secretions of Rhinella, Bufo and Rhaebo species (B. melanosticus, R. schneideri, R. margaritifer, R. hypocondrialis, R. major, R. margaritifera, R. crucifer and R. jimi), bufadienolides extracted from the Chinese traditional drug Ch'an Su and from plants (Urginea maritima, U. aphylla, U. maritima and U. hesperia), displaying activity against tumor lines, such as Table 1 ). (Zhang et al., 1992; Nogawa et al., 2001; Ogasawara et al., 2001; Kamano et al., 2002; Yeh et al., 2003; Cunha-Filho et al., 2010; Sciani et al., 2012; Banuls et al., 2013) . Hellebregenin, for example, is highly cytotoxic to HL-60 cells without causing DNA damage but inducing morphological changes characteristic of cell death by apoptosis (Cunha-Filho et al., 2010) . Previous studies have reported the cytotoxicity of the compounds identified in R. marina (1, 2, 3, and 4) and R. guttatus (2) venoms. Bufalin (3) showed the most potent cytotoxic activity, followed by telocinobufagin (1), resibufogenin (4), and marinobufagin (2) against the following cancer cell lines: leukemia (HL-60), colon (HCT-116), glioblastoma (SF-295), ovarian (OVCAR-8), melanoma (MDA-MB435), human gastric (BGC-823), hepatoma (Bel-7402), cervical carcinoma (HeLa), and primary liver carcinoma (PLC/PRF/5) (Kamano et al., 1998; Ye et al., 2006; CunhaFilho et al., 2010) . The higher cytotoxic activity of venom extracts from R. marina in comparison with R. guttatus can be attributed to the presence of three other bufadienolides (1, 3, and 4) as well as marinobufagin (2), a bufadienolide identified only in R. guttatus venom. The above findings suggest synergistic effects due to the presence of different active principles contributing to the same activity (Wattenberg, 1985) . Thus, it is proposed that compounds present in the extracts act together to kill neoplastic cells.
Regarding chemotherapeutic potential, it is important to determine if the antineoplastic substance shows harmful effects on normal cells (Anazetti et al., 2003; Santos et al., 2010) . Accordingly, primary cultures of PBMC were prepared to assess this injurious potential of the extracts. Surprisingly, most of them were not cytotoxic to PBMC as seen as with transformed cells, where the extract RMF-1 was up to 80-fold more selective against leukemia cells when compared to dividing leukocytes, a very desired advantage in new anticancer leads to overcome adverse effects due to a narrow therapeutic window, multiple drug resistance and morphological and physiological similarities between transformed and normal cells. Meanwhile, Dox showed a selectivity coefficient of 45 determined by IC 50 in PBMC/IC 50 in HL-60.
R. marina extracts did not cause hemolysis even at the highest concentration tested, suggesting that the mechanism of cytotoxicity is probably related to a more specific pathway and is not associated with direct membrane damages. Corroborating these findings, Cunha-Filho et al. (2010) and Sciani et al. (2012) did not find hemolytic activity in amphibian skin secretions from R. crucifer, R. marina, R. schneideri and R. major at a concentration of 50 mg/mL, though secretions of R. jimi, R. margaritifer and Phyllomedusa hypochondrialis showed membrane disruption after 1 h incubation. Divergent results were seen with R. guttatus venom extracts, whereas all exhibited hemolytic potentiality, a contradictory finding when compared to that described by Sciani et al. (2012) , who reported no membrane damage. It is likely that this difference should be correlated with range of concentrations used.
The antiproliferative effects of the extracts were investigated on the basis of the incorporation of BrdU, a thymidine analog, into DNA, which occurs during the S phase of the cell cycle. R. marina extracts caused inhibition of DNA synthesis in HL-60 leukemia as evidenced by the decrease in BrdU incorporation, corroborating outcomes achieved with MTT and Alamar BlueÔ assays. In fact, investigations have demonstrated that some toad skin secretions possess compounds able to induce cell cycle arrest in G 2 /M phase, decrease cell viability, activate initiator and effector caspases and provoke morphological alterations (chromatin condensation, nuclear fragmentation, cytoplasm retraction, cell detachment, membrane blebs and apoptotic bodies) in prostate and breast carcinomas (Yeh et al., 2003; Sciani et al., 2012) . Since cardiotonic steroids of two chemical classes, cardenolides (ouabain, for example) and bufadienolides, bind specifically to the subunits of the sodium/ potassium pump (Na þ /K þ -ATPase) (Newman et al., 2008; Gao et al., 2011) , it is possible that the stimulation of apoptosis by bufadienolides is associated with this bioactivity. In summary, nine extracts of R. marina and R. guttatus venoms showed pronounced lethal and discriminating effects in tumor lines, especially those from R. marina, highlighting toad parotoid gland secretions as a promising source of novel lead anticancer compounds. HPLC and LC-MS analysis of the extracts of R. marina and R. guttatus venom showed significant differences between them, where four bufadienolides (1, 2, 3, and 4) were identified in different extracts from R. marina and only one (2) in R. guttatus.
